Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Company developing targeted oncology therapies spun out of world-leading research at the Wellcome Sanger Institute, in collaboration with the Netherlands Cancer Institute.

From Mosaic Therapeutics 4 Apr 2023

N-abling the acceleration of the life sciences through precision dispensing

In this interview, we speak to Holger Eickhoff, CEO and Founder of Scienion, about their latest technology, The Nucleus Automation Ecosystem.

From SCIENION GmbH 4 Apr 2023

Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

Even as pancreatic cancer treatments improve, only about 9% of patients survive past five years. Researchers have searched unsuccessfully to find genetic differences that explain why some patients survive long term and some do not and have now shifted their focus to the gut microbiome.

3 Apr 2023

3D Printing the Way to New Cancer Treatments

In this interview, we speak to Ishani Malhotra, CEO of Carcinotech, about their 3D-printed tumor replicas that are being used to better understand personalized cancer treatments.

3 Apr 2023

Pathologic complete response can be used as a prognostic factor for clinical outcomes in soft tissue sarcoma patients

Combined long-term survival results from nonrandomized phase II trial NRG Oncology RTOG 0630 and the ancillary analysis of the combined NRG-RTOG 0630/9514 trials indicate that pathologic complete response (pCR) is associated with improved survival outcomes for patients with localized soft tissue sarcoma (STS) who receive preoperative chemoradiotherapy or radiotherapy.

31 Mar 2023

New microfluidic device quickly and automatically predicts the effectiveness of cancer treatment

One of the great challenges in the fight against cancer is to design new technologies for a personalized treatment for each patient.

31 Mar 2023

New model can speed up the evaluation process for drugs used to combat cervical cancer

Researchers at Oregon State University have created a means of speeding up and improving the evaluation process for drugs used to combat cervical cancer.

31 Mar 2023

$3.2 million grant aids in the study of genetic testing approach to close racial disparity gaps in cancer care

With the aid of a near $3.2 million National Cancer Institute grant (R01CA277599) recently awarded, investigators from the state's leading cancer program, Rutgers Cancer Institute of New Jersey,  and Georgetown University's Lombardi Comprehensive Cancer Center, both NCI-designated Comprehensive Cancer Centers, will work to close racial disparity gaps in cancer care delivery by examining a novel approach to genetic testing and care based on community-identified needs.

30 Mar 2023

Study shows how neutrophils play a key role in cancer immunotherapy success

Cancer immunotherapies that recruit a patient's own immune system to destroy tumors have transformed the treatment of many types of cancer. Yet these therapies do not elicit universally good treatment responses.

30 Mar 2023

New research may upend long-held scientific dogma about short telomeres and cancer risk

Johns Hopkins Medicine scientists say their 20-year study of more than 200 people with premature aging syndromes caused by abnormally short telomeres, or shortened repetitive DNA sequences at the ends of chromosomes, may upend long-held scientific dogma and settle conflicting studies about how and whether short telomeres contribute to cancer risk.

30 Mar 2023

Study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation

A newly published study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation.

30 Mar 2023

Study investigates how loss of angulin-1/LSR affects the malignancy of lung adenocarcinoma

A new research paper was published in Oncotarget's Volume 14 on March 24, 2023, entitled, "Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells."

29 Mar 2023

Mouse avatars could help design more effective and personalized therapies for multiple myeloma

An international group of researchers, led by Dr. José Ángel Martínez-Climent at the Cima University of Navarra, has created mouse avatars of patients with multiple myeloma to study and develop personalized treatments against this blood cancer, the second most frequent hematological cancer and incurable in most cases.

29 Mar 2023

Drugs to activate STING could help prevent cancer metastasis

A team of scientists at the Sloan Kettering Institute have identified the STING cellular signaling pathway as a key player in keeping dormant cancer cells from progressing into aggressive tumors months, or even years, after they've escaped from a primary tumor.

29 Mar 2023

Clinical trial of ENZAMET shows promising results for men with advanced prostate cancer

A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.

28 Mar 2023

New technology allows urologists to identify and remove bladder tumors more easily

UC San Diego Health is the first health system in San Diego County to offer a new technology that detects and monitors bladder cancer in both the clinic and operating room settings by using blue light, white light and an imaging dye that makes cancer cells glow florescent pink.

28 Mar 2023

New combination therapy shows promising results in some patients with advanced head and neck cancer

A new combination drug treatment showed promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.

28 Mar 2023

Chemotherapy plus immunotherapy improves outcomes in patients with advanced endometrial cancer

Endometrial cancer, which makes up about 90% of uterine cancers, will be diagnosed in more than 65,000 people in the United States this year.

28 Mar 2023

Avacta appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

Avacta Group plc today announced the appointment of Karen Harrison as Chief Operating Officer of its Therapeutics Division.

From Avacta Life Sciences Ltd. 28 Mar 2023

Surgeons can play an important role in reducing breast cancer disparities

Surgeons can play a key role in reducing breast cancer disparities by increasing their awareness of where disparities exist and having open conversations with their patients about their needs to initiate referrals early on in their care, according to a new collective review article published in the Journal of the American College of Surgeons.

28 Mar 2023

Oncology News and Research

Further Reading

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

N-abling the acceleration of the life sciences through precision dispensing

Long-term pancreatic cancer survivors’ microbiomes have increased levels of specific bacteria

3D Printing the Way to New Cancer Treatments

Pathologic complete response can be used as a prognostic factor for clinical outcomes in soft tissue sarcoma patients

New microfluidic device quickly and automatically predicts the effectiveness of cancer treatment

New model can speed up the evaluation process for drugs used to combat cervical cancer

$3.2 million grant aids in the study of genetic testing approach to close racial disparity gaps in cancer care

Study shows how neutrophils play a key role in cancer immunotherapy success

New research may upend long-held scientific dogma about short telomeres and cancer risk

Study paves the way for some patients with testicular cancer to avoid chemotherapy and radiation

Study investigates how loss of angulin-1/LSR affects the malignancy of lung adenocarcinoma

Mouse avatars could help design more effective and personalized therapies for multiple myeloma

Drugs to activate STING could help prevent cancer metastasis

Clinical trial of ENZAMET shows promising results for men with advanced prostate cancer

New technology allows urologists to identify and remove bladder tumors more easily

New combination therapy shows promising results in some patients with advanced head and neck cancer

Chemotherapy plus immunotherapy improves outcomes in patients with advanced endometrial cancer

Avacta appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

Surgeons can play an important role in reducing breast cancer disparities

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News